Patents Assigned to Soctia Holdings PLC
  • Patent number: 5663202
    Abstract: Damage to the gastrointestinal tract as a consequence of exposure to ionising radiation is prevented or treated by administration of GLA and/or DGLA. Medicaments containing GLA and/or DGLA for such treatment or prevention may also further comprise EPA and/or DHA.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: September 2, 1997
    Assignee: Soctia Holdings PLC
    Inventors: David F. Horrobin, Catherine A. Scott